Structural and functional characterization of a mycobacterial methylenetetrahydrofolate reductase utilizing NADH as the exclusive cofactor
Biochemical Journal · 2023
DOI: 10.1042/bcj20230138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Journal, 2023. Verfasst von Jiacong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Methylenetetrahydrofolate Reductase (NADPH2), NAD. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: NSFC | National Natural Science Foundation of China.
Abstract (Originalsprache)
5,10-Methylenetetraydrofolate reductase (MTHFR) is a key enzyme in folate metabolism. MSMEG_6649, a non-canonical MTHFR from Mycobacterium smegmatis, was previously reported as a monomeric protein lacking the flavin coenzyme. However, the structural basis for its unique flavin-independent catalytic mechanism remains poorly understood. Here, we determined the crystal structures of apo MTHFR MSMEG_6649 and its complex with NADH from M. smegmatis. Structural analysis revealed that the groove formed by the loops 4 and 5 of non-canonical MSMEG_6649 interacting with FAD was significantly larger than that of canonical MTHFR. Meanwhile, the NADH-binding site in MSMEG_6649 is highly similar to the FAD binding site in canonical MTHFR, suggesting that NADH plays the same role (immediate hydride donor for methylenetetraydrofolate) as FAD in the catalytic reaction. Using biochemical analysis, molecular modeling, and site-directed mutagenesis, the critical residues participating in the binding of NADH and the substrate 5,10-methylenetetrahydrofolate as well as the product 5-methyltetrahydrofolate were identified and validated. Taken together, this work not only provides a good starting point for understanding the potential catalytic mechanism for MSMEG_6649, but also identifies an exploitable target for the development of anti-mycobacterial drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogen Biology, School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- The Center for Microbes, Development and Health, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
- School of Pharmaceutical Sciences, Shandong University, Jinan, China.
ORCID-Profile: Wei Lin
Förderung
- NSFC | National Natural Science Foundation of China
Zitieren
APA
Li, J., Yang, M., Li, W., Lu, C., Feng, D., Shang, Z., Wang, C., & Lin, W. (2023). Structural and functional characterization of a mycobacterial methylenetetrahydrofolate reductase utilizing NADH as the exclusive cofactor. Biochemical Journal. https://doi.org/10.1042/bcj20230138
Vancouver
Li J, Yang M, Li W, Lu C, Feng D, Shang Z, et al. Structural and functional characterization of a mycobacterial methylenetetrahydrofolate reductase utilizing NADH as the exclusive cofactor. Biochemical Journal. 2023. doi:10.1042/bcj20230138
BibTeX
@article{Li2023,
author = {Li, Jiacong and Yang, Mingxia and Li, Weijia and Lu, Chujie and Feng, Deyu and Shang, Zhuo and Wang, Chengyuan and Lin, Wei},
title = {Structural and functional characterization of a mycobacterial methylenetetrahydrofolate reductase utilizing NADH as the exclusive cofactor},
journal = {Biochemical Journal},
year = {2023},
doi = {10.1042/bcj20230138}
}
EUVIMED